COUGH STOP MIXTURE

Indications

• Acute cough
• Chronic cough
• Cough due to respiratory infections
• Cough associated with asthma
• Cough in chronic obstructive pulmonary disease (COPD)
• Allergic cough
• Post-nasal drip syndrome

Dosage

Children: Refer to the BNF for Children for specific dosing information based on the selected medication and age of the child.

Adults: Refer to the BNF for specific dosing information based on the selected medication and indication for cough.

Mechanism of action

Cough medications can act through various mechanisms depending on their classification. Cough suppressants (antitussives) like dextromethorphan inhibit the cough reflex in the brain, while expectorants like guaifenesin increase mucus secretion, making it easier to expel. Mucolytics, such as acetylcysteine, break down mucus structure, facilitating clearance from the airways.

Pharmacodynamics

The pharmacodynamics of cough medications vary widely. Antitussives primarily reduce the sensitivity of the cough reflex pathways in the central nervous system. Expectorants promote increased mucus production and reduce viscosity, aiding in expectoration. Mucolytics alter the physical properties of mucus, enhancing its clearance from the respiratory tract.

Pharmacokinetics

The pharmacokinetics of cough medications differ among classes. Antitussives are generally well-absorbed orally, with peak plasma concentrations occurring within 1-2 hours. They are metabolized in the liver and excreted primarily through urine. Expectorants and mucolytics also exhibit similar absorption profiles and are eliminated through renal pathways, although their metabolism may involve different enzymatic processes in the liver.

Pregnancy

Consult with a healthcare provider for advice regarding use during pregnancy.

Breast-feeding

Consult a healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Pain relief
• Fever reduction
• Treatment of respiratory conditions
• Management of inflammation
• Cough relief
• Antibiotic therapy

Dosage

Children: Refer to the BNF for Children for specific dosing guidelines tailored to paediatric populations, as dosages will depend on the formulation and active ingredients used in the mixture.

Adults: Refer to specific drug combinations for appropriate dosing recommendations, as dosages will vary widely based on the active ingredients included.

Mechanism of action

The mechanism of action of a mixture depends on the specific active ingredients included. For instance, if the mixture consists of an analgesic and an anti-inflammatory, the analgesic may work by inhibiting cyclooxygenase enzymes, thus reducing prostaglandin synthesis, while the anti-inflammatory may reduce inflammation through modulation of immune cell activity. The synergistic effects can enhance overall therapeutic outcomes.

Pharmacodynamics

Pharmacodynamics of mixtures varies based on the components involved. Each ingredient may exert its pharmacological effects through different pathways, leading to a combined effect that is often greater than the sum of individual drugs. This can involve interactions at receptor sites, modulation of enzyme activity, or alteration of metabolic pathways, improving clinical outcomes for patients.

Pharmacokinetics

Pharmacokinetics of drug mixtures is influenced by the individual pharmacokinetic profiles of each constituent. This includes absorption rates, distribution volumes, metabolism pathways, and elimination half-lives. The presence of multiple active ingredients can lead to altered absorption due to interactions, changes in protein binding, or competition for metabolic enzymes. Understanding these dynamics is crucial for optimizing dosing regimens and minimizing potential adverse effects.

Pregnancy

The safety of this mixture during pregnancy has not been established. Use only if the potential benefits outweigh the risks.

Breast-feeding

Caution is advised when using this mixture while breastfeeding. Consult a healthcare professional for guidance.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Ensure that the container is tightly closed.

Indications

• Dental caries prevention
• Management of gingivitis
• Enamel mineralization enhancement

Dosage

Children: Refer to the BNF for Children for appropriate dosing recommendations.

Adults: Refer to the specific product guidelines or consult the BNF for appropriate dosing recommendations.

Mechanism of action

Stannous fluoride manages and prevents dental caries and gingivitis by promoting enamel mineralization and depositing a stable acid-resistant layer composed of calcium fluoride on tooth surfaces. This occurs when stannous fluoride converts calcium mineral apatite into fluorapatite. It modulates microbial composition and has a potential broad-spectrum antibiotic effect. The efficacy relies on tin incorporation in mineralized dentine and surface precipitation when the organic portion is preserved.

Pharmacodynamics

Stannous fluoride exhibits both bactericidal and bacteriostatic properties, mediating an anti-erosive action on tooth enamel. Its effectiveness is influenced by the interaction with salivary proteins, enhancing the protective layer against erosion and reducing the acidogenicity of dental plaque.

Pharmacokinetics

The pharmacokinetics of stannous fluoride in the context of dental applications primarily focuses on local effects rather than systemic absorption. Its action is localized on the teeth and oral cavity, where it exerts its preventive measures against caries and gingivitis.

Pregnancy

Stannous fluoride is generally considered safe for use during pregnancy, but it is advisable to consult a healthcare professional for individual assessment.

Breast-feeding

Stannous fluoride is considered safe during breastfeeding; however, consultation with a healthcare professional is recommended.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• 0.2% aqueous solution
• toothpaste containing stannous fluoride

Mechanism of action

Stannous fluoride has been shown to manage and prevent dental caries and gingivitis by promoting enamel mineralization, reducing gingival inflammation and bleeding, its potential broad-spectrum antibiotic effect, and through modulation of the microbial composition of the dental biofilm. It works by depositing a stable acid-resistant layer on the tooth surfaces which is composed of calcium fluoride produced when stannous fluoride converts the calcium mineral apatite into fluorapatite. Tin and fluoride mediate anti-erosive actions by interacting with and modifying the absorbent layer composed of salivary proteins such as mucins, perhaps by enhancing the cross-linking between the proteins to result in a more resistant and protective layer against erosion. The efficacy of stannous fluoride solutions seems to depend mainly on the incorporation of tin in the mineralized dentine when the organic portion is preserved but on surface precipitation when the organic portion is continuously digested. Moreover, the relative erosion-inhibiting effects of stannous fluoride strongly depend on the presence or absence of the demineralized organic dentine matrix. DENTAL STUDENTS RINSED FOR 4 DAYS WITH 0.2% AQ SOLN STANNOUS FLUORIDE OR STANNIC TETRACHLORIDE & IN ADDITION 15% SUCROSE TO ENHANCE PLAQUE FORMATION. TIN(2+) SHOWED MARKED INHIBITING ACTIVITY WHEREAS THE TIN(4+) SHOWED ONLY SLIGHT EFFECT. THE TIN(2+) ION ALSO REDUCED THE ACIDOGENICITY OF THE DENTAL PLAQUE WHEREAS THE TIN(4+) SHOWED NO EFFECT. TIN(2+) REDUCES METABOLIC ACTIVITY OF PLAQUE BY OXIDIZING THIOL GROUPS BY AFFINITY FOR THEM. THIS IS NOT THE CASE FOR TIN(4+). /STANNOUS FLUORIDE/ ... ALTERS THE COMPOSITION & CRYSTALLINE STRUCTURE OF THE HYDROXYAPATITE-LIKE SALTS THAT MAKE UP THE BULK OF ENAMEL, ESPECIALLY, & DENTIN, SO THAT THE TOOTH MATERIAL IS MORE RESISTANT TO ACIDIC EROSION & DENTAL CARIES (DECAY). When stannous fluoride is applied topically to teeth, a highly adherent surface coating composed mainly of tin phosphate and smaller amounts of calcium fluoride and a tin hydroxyorthophosphate is formed on enamel. IN A STANDARDIZED RABBIT MODEL, YELLOW GOLDEN STAIN FORMED ON TOOTH SURFACES DURING USE OF STANNOUS FLUORIDE IS DUE TO ITS LOW PH WHICH CAUSES DENATURATION OF PELLICLE PROTEIN WITH EXPOSURE TO SULFHYDRYL GROUPS, WHICH FORM STANNIC SULFIDES THROUGH REACTIONS WITH TIN(2+).

Pharmacodynamics

Stannous fluoride mediates both bactericidal and bacteriostatic properties and provides an anti-erosive action on tooth enamel.